Search Results

A US national survey, presented at CHEST 2009, provides evidence of multiple serious and fatal errors associated with prostacyclin agonist infusion

Source: Reactions, Volume 1, Number 1282, 2009-12-12 , pp. 7-7(1)

Publisher: Adis International

Sildenafil most cost effective PAH treatment

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 587, 2009-09-19 , pp. 3-3(1)

Publisher: Adis International

Cost-Utility of Treatments for Pulmonary Arterial Hypertension: A Markov State-Transition Decision Analysis Model

Authors: Garin, Margaret C.; Clark, Leslie; Chumney, Elinor C.G.; Simpson, Kit N.; Highland, Kristin B.

Source: Clinical Drug Investigation, Volume 29, Number 10, 1 October 2009 , pp. 635-646(12)

Publisher: Adis International

Pulmonary Arterial Hypertension in Connective Tissue Diseases

Authors: Bodini, Bruno D.; Sitia, Simona; Tomasoni, Livio; Longhi, Matteo; Turiel, Maurizio

Source: Current Respiratory Medicine Reviews, Volume 5, Number 2, May 2009 , pp. 115-119(5)

Publisher: Bentham Science Publishers

Treprostinil overdose: Arm tingling, nausea, blurred vision, flushing and reduced motor control in a child: case report

Source: Reactions, Volume 1, Number 1249, 2009-04-25 , pp. 44-44(1)

Publisher: Adis International

Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease

Authors: Sakai, Tetsuro; Planinsic, Raymond M.; Mathier, Michael A.; de Vera, Michael E.; Venkataramanan, Raman

Source: Transplant International, Volume 22, Number 5, May 2009 , pp. 554-561(8)

Publisher: Blackwell Publishing

Treprostinil may not offer freedom from PAH

Source: Inpharma, Volume 1, Number 1666, 2008-11-29 , pp. 18-18(1)

Publisher: Adis International

A rapid-escalation treprostinil regimen is at least as effective and well tolerated as a slow-escalation regimen

Source: Inpharma, Volume 1, Number 1656, 2008-09-20 , pp. 18-18(1)

Publisher: Adis International

Treprostinil NDA accepted for review by US FDA.

Source: Inpharma, Volume 1, Number 1655, 2008-09-13 , pp. 19-19(1)

Publisher: Adis International

The Role of Treprostinil in the Management of Pulmonary Hypertension

Authors: Skoro-Sajer, Nika; Lang, Irene

Source: American Journal of Cardiovascular Drugs, Volume 8, Number 4, 2008 , pp. 213-217(5)

Publisher: Adis International

A Clinical Comparison of Slow- and Rapid-Escalation Treprostinil Dosing Regimens in Patients with Pulmonary Hypertension

Authors: Skoro-Sajer, Nika; Lang, Irene M.; Harja, Evis; Kneussl, Meinhard P.; Gin Sing, Wendy; Gibbs, Simon J.R.

Source: Clinical Pharmacokinetics, Volume 47, Number 9, 2008 , pp. 611-618(8)

Publisher: Adis International

Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension

Authors: Doran, A. K.; Ivy, D. D.; Barst, R. J.; Hill, N.; Murali, S.; Benza, R. L.

Source: International Journal of Clinical Practice, Volume 62, Supplement 160, July 2008 , pp. 5-9(5)

Publisher: Blackwell Publishing

R&D news from ATS

Source: Inpharma, Volume 1, Number 1643, 2008-06-21 , pp. 10-10(1)

Publisher: Adis International

Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome

Authors: Galie, Nazzareno; Manes, Alessandra; Palazzini, Massimiliano; Negro, Luca; Marinelli, Alessandro; Gambetti, Simona; Mariucci, Elisabetta; Donti, Andrea; Branzi, Angelo; Picchio, Fernando M.

Source: Drugs, Volume 68, Number 8, 2008 , pp. 1049-1066(18)

Publisher: Adis International

Switching from IV epoprostenol to SC treprostinil is "safe and efficacious" for patients with pulmonary arterial hypertension

Source: Inpharma, Volume 1, Number 1611, 2007-10-27 , pp. 16-16(1)

Publisher: Adis International

Expert opinion on available options treating pulmonary arterial hypertension

Authors: Naeije, Robert; Huez, Sandrine

Source: Expert Opinion on Pharmacotherapy, Volume 8, Number 14, October 2007 , pp. 2247-2265(19)

Publisher: Informa Healthcare

Therapeutic Challenges for Systemic Sclerosis

Authors: CERINIC MATUCCI, M.; DEL ROSSO, ANGELA; FEDERICO, PERFETTO; LIVI, RICCARDO; FIORI, GINEVRA; BARTOLI, FRANCESCA; BLAGOJEVIC, JELENA; TEMPESTINI, ALESSIO; PIGNONE, ALBERTO

Source: Annals of the New York Academy of Sciences, Volume 1110, Number 1, September 2007 , pp. 448-454(7)

Publisher: Blackwell Publishing

Bloodstream infections more frequent with treprostinil

Source: Reactions, Volume 1, Number 1143, 2007-03-17 , pp. 1-1(1)

Publisher: Adis International

Molecular Targets for Promoting Wound Healing in Diabetes

Authors: Pradhan, Leena; Andersen, Nicholas D.; LoGerfo, Frank W.; Veves, Aristidis

Source: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Volume 1, Number 1, February 2007 , pp. 1-13(13)

Publisher: Bentham Science Publishers

Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension

Authors: SKORO-SAJER, N.; BONDERMAN, D.; WIESBAUER, F.; HARJA, E.; JAKOWITSCH, J.; KLEPETKO, W.; KNEUSSL, M. P.; LANG, I. M.

Source: Journal of Thrombosis and Haemostasis, Volume 5, Number 3, March 2007 , pp. 483-489(7)

Publisher: Blackwell Publishing